Latest Breaking News On - Onxeo sa euronext - Page 7 : comparemela.com

Combined General Meeting of August 17, 2022: Onxeo Shareholders Approve Withdrawal From the Nasdaq First North Market in Copenhagen

Combined General Meeting of August 17, 2022: Onxeo Shareholders Approve Withdrawal From the Nasdaq First North Market in Copenhagen
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Arthur rouillOnxeo sa euronextEmmanuel huynhCompany groupEuronext growthNasdaq first northCombined general meetingNasdaq firstGeneral meetingsEuronext parisStrategic communication

Onxeo S A : Combined General Meeting of August 17, 2022: Onxeo Shareholders Approve Withdrawal From the Nasdaq First North Market in Copenhagen

Company to submit delisting request to Nasdaq Regulatory News: Onxeo S.A. (Euronext Growth: ALONX, Nasdaq First North: ONXEO), a clinical-stage biotechnology company specializing in the development

Arthur rouillOnxeo sa euronextEmmanuel huynhCompany groupEuronext growthNasdaq first northCombined general meetingNasdaq firstGeneral meetingsEuronext paris

Onxeo S A : Combined General Meeting of August 17, 2022: Availability of Preparatory Documents and Participation & Voting Procedures

Onxeo S A : Combined General Meeting of August 17, 2022: Availability of Preparatory Documents and Participation & Voting Procedures
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalArthur rouillOnxeo sa euronextEmmanuel huynhCompany groupRegulatory newsEuronext growthNasdaq first northCombined general meetingGeneral meetingGeneral meetingsInvestor relationsEuronext paris

Onxeo S A : Onxeo Announces a Combined General Meeting on August 17, 2022

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: ONXEO), hereafter "Onxeo" or the "Company", a clinical-stage biotechnology company specializing in the development

France generalArthur rouillRaymond poincarOnxeo sa euronextEmmanuel huynhRenaissance paris nobel tour eiffel hotelCompany groupRegulatory newsEuronext growth parisNasdaq first north copenhagenCombined general meetingMandatory legal noticesNasdaq first northEuronext growthGeneral meetingssectionInvestor relations

Onxeo: Initial IND Application for AsiDNA Granted Study May Proceed by the U S FDA

Onxeo: Initial IND Application for AsiDNA Granted Study May Proceed by the U S FDA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalShefali agarwalArthur rouillOnxeo sa euronextEmmanuel huynhDrug administrationCompany groupEuronext growth parisNasdaq first north copenhagenEuronext parisStrategic communicationNasdaq first north